Brazil’s transactional market recorded 374 deals totaling BRL 123.2 billion in the first four months of 2026, with Mattos Filho emerging as the top legal advisor by both deal count and value, according to TTR Data’s latest report.
Madrona Advogados advised Independence Equipamentos de Segurança on the acquisition of 100% of the shares of Matcon, a company specializing in the import and commercialization of construction materials.
Dias Carneiro Advogados advised Affinitas Bidco Limited on its entry into the Brazilian market through the acquisition of Saint Francis International School, marking the British group's debut in Brazil's education sector.
Cescon Barrieu advised Brazilian digital credit platform MeuTudo and its controlling shareholders on a strategic investment by Banco BTG Pactual, in a transaction valued at over BRL 1 billion that combines a BRL 587 million equity subscription
Santos Neto Advogados and Mattos Filho have advised on Amaggi's acquisition of a 40% equity stake in FS Bioenergia, a corn ethanol producer controlled by Summit Agricultural Group, in a transaction requiring CADE approval.
Bumachar Advogados Associados, led by Juliana Bumachar, has launched Bumachar Consultancy, a new strategic advisory arm focused on cross-border transactions between Brazil and the United States.
Mattos Filho has promoted six lawyers to partner, four of whom are women, bringing the firm's total partner count to 144. The promotions span six practice areas across São Paulo and Rio de Janeiro.
Demarest advised Norwegian company Elkem ASA on the Brazilian aspects of the $2 billion sale of its Silicones division to China National Bluestar, covering local corporate and regulatory steps required for the transfer of Elkem Silicones
FittipaldiGômara Advogados has incorporated the labor practice of PMMF Advogados, with attorney Fabiana Fittipaldi Morade leading the incoming team as part of a structured expansion of the firm's employment and labor law capabilities.
Madrona Advogados advised Alaska Asset Management on the acquisition of a 26.15% stake in Biomm through a stock exchange auction, in a deal valued at BRL 260 million that reshaped the pharmaceutical company's shareholder structure.
